Welcome to our dedicated page for Nutex Health news (Ticker: NUTX), a resource for investors and traders seeking the latest updates and insights on Nutex Health stock.
Nutex Health Inc. operates as a physician-led healthcare services and operations company with a Hospital Division and a Population Health Management Division. Its hospital operations own, develop and operate micro-hospitals, specialty hospitals and hospital outpatient departments, while the population health business owns provider networks such as independent physician associations and provides management and administrative support through a management services organization.
Company news commonly covers quarterly and annual financial results, hospital openings and reopenings, expansion of facility operations across states, risk-bearing physician network activity, real estate-backed hospital development, earnings calls, healthcare conference participation and common stock repurchase authorizations.
Nutex Health (NASDAQ: NUTX) reported Q1 2026 results for the quarter ended March 31, 2026: total revenue $216.5M (up 2.2% year-over-year), net income attributable $46.8M (diluted EPS $6.52), EBITDA $68.3M, Adjusted EBITDA $57.6M, and operating cash flow $75.5M. Cash and cash equivalents totaled $207.3M and long-term debt, net declined to $24.3M. Hospital division visits increased 3.1% and same-hospital revenue rose 0.2%.
Nutex Health (NASDAQ: NUTX) will file its Form 10-Q for the quarter ended March 31, 2026, and issue a press release with financial results on April 30, 2026 after market close.
The company will host an earnings conference call on May 1, 2026 at 9:30 a.m. CT; a recording and transcript will be posted under Investor Materials.
Nutex Health (NASDAQ: NUTX) reported full-year 2025 results with total revenue of $875.3M, up 82.4% versus 2024, and net income attributable of $70.8M. Hospital division revenue was $844.2M, driven partly by IDR arbitration outcomes. The Board authorized a $25.0M share repurchase program over six months.
Full-year Adjusted EBITDA was $259.6M, cash from operations was $248.1M, cash and equivalents ended at $185.6M, and stock-based compensation rose to $117.0M.
Nutex Health (NASDAQ: NUTX) said it will file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 on Thursday, March 5, 2026, after market close and will issue a press release summarizing results the same day.
The company will host an earnings conference call on Friday, March 6, 2026 at 9:30 a.m. CT. Participant dial-ins, a Call Me™ link that activates 15 minutes before start, and a post-call transcript and recording will be available on the company's Investor Materials webpage.
Nutex Health (NASDAQ: NUTX) announced the reopening of Bayou City ER & Hospital in Humble, Texas on January 12, 2026. The 40,000 square foot facility is described as Nutex's largest hospital and offers 24/7/365 concierge-level care with 8 emergency room beds and 46 inpatient beds. The site includes a full-service laboratory and advanced imaging (CT, X-ray, ultrasound) with same-day scheduling and rapid results. Leadership framed the reopening as a milestone to expand access to specialized services in Northeast Houston, including behavioral health and medical detox.
Nutex Health (NASDAQ: NUTX) will attend and present at the 2026 J.P. Morgan Healthcare Conference in San Francisco on January 12–15, 2026. Company executives attending include CEO Tom Vo, M.D., MBA, CFO Jon Bates, and President Warren Hosseinion. Nutex Health's presentation is scheduled for Wednesday, January 14, 2026 at 4:30 PM PST at The Westin St. Francis.
The company is a physician-led integrated healthcare delivery system operating 26 micro hospitals and hospital outpatient departments across 12 states, with primary care-centric risk-bearing physician networks.
Nutex Health (NASDAQ: NUTX) opened Archview ER & Hospital in St. Louis on December 22, 2025, marking its 26th hospital and its first location in Missouri.
The 16,000 sq ft facility at 1320 N. Jefferson Ave offers 15 emergency beds, 3 inpatient suites, a full-service laboratory and advanced imaging (MRI, CT, X-ray, ultrasound) with same-day scheduling, and 24/7/365 concierge-level care.
The site is positioned in North St. Louis with views of the Gateway Arch and proximity to the National Geospatial-Intelligence Agency campus.
Nutex Health (NASDAQ: NUTX) announced its Board has extended a previously authorized $25.0 million common stock repurchase program through March 31, 2026. The program, first authorized Aug 14, 2025, began upon filing the Form 10-Q for the quarter ended June 30, 2025 and will be executed under Rule 10b-18 and a Rule 10b5-1 trading plan scheduled to take effect on or about Dec 4, 2025. The company said the buyback aims to increase shareholder value and offset dilution from stock compensation for under-construction and ramping hospitals. Repurchases remain discretionary and may be affected by market, financial, legal and capital considerations.
Summary not available.
Nutex Health (NASDAQ: NUTX) announced the reopening of Red River ER & Hospital in Sherman, Texas on November 24, 2025. The 18,500 sq ft facility offers 24/7/365 concierge-level care with seven ER beds, four inpatient suites, and two triage rooms. The site includes a full-service laboratory and advanced imaging (MRI, CT, X-ray, ultrasound) with same-day scheduling and rapid results.
Company leaders highlighted the hospital's role serving the growing Sherman area and nearby Oklahoma communities and emphasized upgraded equipment, reduced wait times, and around-the-clock clinical staffing.